The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
As of close of business last night, Alx Oncology Holdings Inc’s stock clocked out at $0.6, up 2.93% from its previous closing price of $0.58. In other words, the price has increased by $2.93 from its previous closing price. On the day, 0.56 million shares were traded. ALXO stock price reached its highest trading level at $0.615 during the session, while it also had its lowest trading level at $0.5703.
Ratios:
To gain a deeper understanding of ALXO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.47 and its Current Ratio is at 5.47. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on March 06, 2025, Upgraded its rating to Buy and sets its target price to $3 from $2 previously.
On December 19, 2024, Jefferies Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $12 to $2.
Stifel Downgraded its Buy to Hold on March 08, 2024, whereas the target price for the stock was revised from $10 to $14.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 07 ’25 when Pinto Shelly sold 2,011 shares for $0.45 per share. The transaction valued at 905 led to the insider holds 86,809 shares of the business.
Pinto Shelly sold 1,532 shares of ALXO for $659 on Jun 30 ’25. The SVP, FINANCE AND CAO now owns 88,820 shares after completing the transaction at $0.43 per share. On Feb 19 ’25, another insider, Pinto Shelly, who serves as the SVP, FINANCE AND CAO of the company, sold 550 shares for $1.15 each. As a result, the insider received 633 and left with 87,352 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALXO now has a Market Capitalization of 31906068 and an Enterprise Value of -49339920.
Stock Price History:
The Beta on a monthly basis for ALXO is 1.16, which has changed by -0.7867857 over the last 52 weeks, in comparison to a change of 0.16821623 over the same period for the S&P500. Over the past 52 weeks, ALXO has reached a high of $6.02, while it has fallen to a 52-week low of $0.40. The 50-Day Moving Average of the stock is 21.21%, while the 200-Day Moving Average is calculated to be -40.36%.
Shares Statistics:
It appears that ALXO traded 534.81K shares on average per day over the past three months and 704740 shares per day over the past ten days. A total of 53.38M shares are outstanding, with a floating share count of 36.79M. Insiders hold about 31.17% of the company’s shares, while institutions hold 45.90% stake in the company. Shares short for ALXO as of 1752537600 were 4389742 with a Short Ratio of 8.21, compared to 1749772800 on 5437599. Therefore, it implies a Short% of Shares Outstanding of 4389742 and a Short% of Float of 13.08.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
